We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RVMD market cap is 7.29B. The company's latest EPS is USD -3.2278 and P/E is -0.02.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 742k | 0 | 0 | 0 | 0 |
| Operating Income | -179.98M | -140.86M | -156.64M | -175.71M | -216.31M |
| Net Income | -161.54M | -116M | -133.23M | -156.29M | -194.57M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.98M | 29.39M | 35.38M | 11.58M | 0 |
| Operating Income | -110.7M | -188.01M | -258.28M | -487.19M | -689.52M |
| Net Income | -110.38M | -187.09M | -248.71M | -436.37M | -600.09M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.06B | 1.91B | 1.81B | 1.76B | 2.56B |
| Total Liabilities | 235.51M | 182.9M | 189.59M | 196.7M | 293.1M |
| Total Equity | 1.83B | 1.73B | 1.62B | 1.57B | 2.27B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 567.4M | 737.99M | 811.93M | 2.06B | 2.56B |
| Total Liabilities | 92.73M | 135.42M | 126.74M | 235.51M | 293.1M |
| Total Equity | 474.68M | 602.57M | 685.19M | 1.83B | 2.27B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -350.57M | -160.56M | -288.73M | -419.15M | -557.44M |
| Investing | -342.6M | -247.97M | -140.02M | -161.49M | -554.39M |
| Financing | 1.23B | 810k | 8.31M | 85.61M | 959.41M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -100.06M | -147.18M | -224.4M | -350.57M | -557.44M |
| Investing | -234.23M | -142.12M | -24.12M | -342.6M | -554.39M |
| Financing | 422.78M | 294.18M | 301.43M | 1.23B | 959.41M |
| Market Cap | 7.29B |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.02 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 185.91M |
| Average Volume (1 week) | 1.59M |
| Average Volume (1 Month) | 1.3M |
| 52 Week Change | 25.83% |
| 52 Week High | 62.40 |
| 52 Week Low | 29.74 |
| Spread (Intraday) | 20 (35.09%) |
| Company Name | Revolution Medicines Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.revmed.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
